Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive

Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.

4/434 Publicaciones

Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.

Köksal İ et al. · Turk J Gastroenterol · 2018

FibroTest HCV
Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

Usluer G et al. · Eur J Clin Microbiol Infect Dis · 2012

FibroTest HCV
Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.

Canbakan M et al. · Nephron Clin Pract · 2011

FibroTest HCV
The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.

Sökücü S et al. · Scand J Infect Dis · 2010

ActiTest FibroTest HBV

Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.

Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.

Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.

The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.